Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1) [Phase 2]

View source ↗

Summary

Phase 2 trial update for CBL-514 in cellulite (Stage 1) completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulite

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Cellulite | Phase 2 | Status: COMPLETED